G. Shurin

Comparative analysis of CD1a, S-100, CD83, and CD11c human dendritic cells in normal, premalignant, and malignant tissues.

M. Shurin, I. Tourkova, L. Perez, 2005, Histology and histopathology.

Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo.

R. Ferris, A. Lokshin, G. Chatta, 2006, The Journal of Immunology.

TNF-α protects dendritic cells from prostate cancer-induced apoptosis

M. Shurin, G. Pirtskhalaishvili, C. Esche, 2001, Prostate Cancer and Prostatic Diseases.

Tumor's other immune targets: dendritic cells

Simon C Watkins, M. Lotze, A. Lokshin, 1999, Journal of leukocyte biology.

Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function.

M. Lotze, G. Shurin, M. Shurin, 2001, Cancer research.

Mechanisms of dendritic cell-induced T cell proliferation in the primary MLR assay.

Z. Yurkovetsky, G. Shurin, M. Shurin, 2001, Immunology letters.

Tumor necrosis factor-alpha-promoted expression of Bcl-2 and inhibition of mitochondrial cytochrome c release mediate resistance of mature dendritic cells to melanoma-induced apoptosis.

J. Kirkwood, G. Shurin, M. Shurin, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

ChemoImmunoModulation: immune regulation by the antineoplastic chemotherapeutic agents.

G. Shurin, M. Shurin, V. Umansky, 2012, Current medicinal chemistry.

Human renal cell carcinoma inhibits dendritic cell maturation and functions

G. Chatta, G. Shurin, M. Shurin, 2004, Der Urologe.

© 2000 Cancer Research Campaign

M. Lotze, G. Shurin, M. Shurin, 2022 .

Hypothalamic-pituitary-adrenal activation by the bacterial superantigen staphylococcal enterotoxin B: role of macrophages and T cells.

A. Kusnecov, G. Hoffman, G. Shurin, 1997, Neuroendocrinology.